Venture Capital Investors

Forbion Growth Opportunities Fund II

VC firm Forbion Growth Opportunities Fund II provides capital to high-potential high-tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

The Forbion Growth Opportunities Fund II builds on the strength of Forbion's first Growth Fund. The fund is focused on investing primarily in European later-stage biopharma companies developing novel therapies in areas of high medical need. In these financings, the team aims to take leading positions with investment sizes of up to �70 million per deal. The fund has attracted several new institutional investors, including Amundi and Legal & General Capital which join Dutch pension funds PME and PMT, Pantheon and Eli Lilly and Company. The Forbion Growth Opportunities Fund II has already made four investments to date.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/14/2023

Transaction History

Our records indicate that Forbion Growth Opportunities Fund II invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Contact

First Last

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Forbion Growth Opportunities Fund II has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Forbion Capital Partners | Forbion Ventures Fund VI

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary